Form 4 for LIVN LivaNova PLC
Accepted 2025-09-17 00:00:00 ET · period of report 2025-09-15 · accession 0001639691-25-000135 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-17 | 2025-09-15 | LIVN | Poletti Franco | Pres, Cardiopulmonary | F - Tax | $55.43 | -277 | 8,299 | -3% | -$15.4K |
| D | 2025-09-17 | 2025-09-15 | LIVN | Poletti Franco | Pres, Cardiopulmonary | M - OptEx | $0.00 | +643 | 8,576 | +8% | $0 |
| D | 2025-09-17 | 2025-09-15 | LIVN | Poletti Franco | Pres, Cardiopulmonary | M - OptEx | $0.00 | -643 | 1,932 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-09-15 | F | D | 277 | $55.43 | 8,299 | D | — | — | (F2) Shares withheld to satisfy tax liability. |
| 2 | Common | Ordinary Shares | 2025-09-15 | M | A | 643 | $0.00 | 8,576 | D | — | — | (F1) Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value. |
| 3 | Derivative | Restricted Stock Units | 2025-09-15 | M | D | 643 | $0.00 | 1,932 | D | — · — to — | 643 Ordinary Shares | (F3) Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the "Plan") and the award agreement. (F4) On September 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments. The first vesting occurred on September 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. |